EC Healthcare Collaborates with New Horizon Health to form Strategic Partnership To Jointly Launch CerviClear in Hong Kong

Delegated right: Mr. ZHENG Weixian Senior Director of Operation management, New Horizon Health, Dr. Rita Shih Head of International R&D Center, New Horizon Health, Mr. Li Yan Vice President, New Horizon Health, Mr. Zhu YeQing Chairman and CEO, New Horizon Health, Mr. Leslie LU Executive Director and Co-Chief Executive Officer, EC Healthcare, Dr. Eric CHU Chief Business Officer, EC Healthcare, Dr. Julie CHOW Chief Proposition Officer (Healthcare), EC Healthcare

Cervical cancer is a typical deadly growth for females. The morbidity and death have actually been increasing over the last few years, with a significant pattern of renewal. Cervical cancer is likewise the only cancer with apparent cause and can be removed through early intervention. Established by New Horizon Health, CerviClear is the very first Urine-based HPV Detection and Cervical Cancer Screening Test worldwide. It is the only item thoroughly covering all 14 high-risk HPV infection and accomplishes non-invasive home-based urine self-sampling. The item has actually currently gotten a CE Mark, and is received releasing in Hong Kong and the Greater Bay Area.

Mr. Leslie Lu, Executive Director and Co-CEO of EC Healthcare stated, “We are happy to partner with New Horizon Health, a leading cancer screening business. The Group treasures tactical cooperation with upstream partners in the pharmaceutical field as the core technique. Through cooperation with partners in biotech and pharmaceutical market, the Group will even more enhance the preventive medication market impact and more combine its market leading position. This Partnership allows the Group to even more diversify its service item mix by leveraging vaccination, medical examination and several medical specializeds services to finish the one-stop environment. Our company believe the cooperation will likewise speed up the Group to attain vertical combination of the market worth chain.”

Mr. Zhu Yeqing, Executive Director and CEO of New Horizon Health stated: “The efficient method to promote the avoidance of high-risk cancer is to supply practical, trusted and certified ingenious screening items. CerviClear is the very first item worldwide that accomplishes urine self-sampling. Compared to the scientific assessment, clients no longer requires to go to a medical facility and the tasting treatment is non-invasive and pain-free. It is anticipated to considerably reduce the time expense and pressure level for clients. EC Healthcare is the leading health care companies in both Hong Kong and the Greater Bay Area. We are thankful to partner with EC Healthcare and think the collaboration ends up being a turning point for our pipeline and development commercialization.”

About EC Healthcare
EC Healthcare is Hong Kong’s biggest non-hospital medical provider *, leveraging its core companies of preventive and accuracy medication, and dedicated to establishing medical expert system by incorporating its multi-disciplinary medical services. The relocation, which is supported by the Group’s high-end branding and quality customer care, is targeted at providing consumers safe and reliable health care and medical services with professionalism. The Group is a constituent stock of the Hang Seng Composite Index and the MSCI Hong Kong Small Cap Index.

The Group primarily takes part in the arrangement of one-stop medical and healthcare services in Greater China. The Group offers a complete variety of services and items under its widely known brand names, consisting of those of its one-stop visual medical services service provider DR REBORN which has actually ranked initially in Hong Kong by sales for years, an expert hair care center HAIR FOREST, main care centers collectively developed with health management centre re: HEALTH, a vaccine centre Hong Kong Professional Vaccine HKPV, General outpatient center Tencent Doctorwork, the biggest one-stop discomfort management centre in Hong Kong New York Medical Group, the extensive oral centres Bayley & & Jackson Dental Surgeons, EC DENTAL CARE and Health and Care Dental Clinic, an innovative diagnostic and imaging centre HKAI, an oncology treatment centre reVIVE, a day treatment centre HKMED, a specialized center PREMIER MEDICAL CENTRE, SPECIALISTS CENTRAL and NEW MEDICAL CENTER, a paediatric centre PRIME CARE, a gynaecology expert ZENITH MEDICAL CENTER AND PRENATAL DIAGNOSIS CENTRE, PathLab Medical Laboratories, Ophthalmology Center VIVID EYE and EC Veterinary Hospital and Imaging.

* According to independent research study carried out by Frost and Sullivan in regards to earnings in 2020 and 2021

About New Horizon Health
Established in 2015, New Horizon Health is a leader and leader in China’s cancer screening market, concentrating on early house screening of high-incidence cancers, intending to promote development in cancer screening innovation and speed up the appeal of cancer screening innovation in China. On February 18, 2021, New Horizon Health was effectively noted on the SEHK with stock code 6606. HK, which ended up being “the very first noted Chinese cancer early screening business”.

New Horizon Health has actually 3 marketed items. ColoClear, Pupu Tube and UU Tube have actually all been authorized by the National Medical Products Administration of China and are formally advertised. ColoClear is the only cancer screening item authorized by the National Medical Products Administration of China for individuals aged 40-74 who are at high threat of colorectal cancer. UU Tube is the only customer self-test item for Helicobacter pylori authorized by the National Medical Products Administration of China. Pupu Tube is the very first FIT at-home self-test gadget authorized in China. In addition, the Company has 3 pipelines of items in advancement for liver cancer (LiverClear), cervical cancer (CerviClear) and nasopharyngeal cancer screening. The Company has international rights to all of its marketed and pipeline items.

New Horizon Health works thoroughly with numerous health centers, health check-ups, insurer, drug stores and online channels. The Company has a class 100,000 tidy production workshop that fulfills ISO13485 and ISO9001 worldwide accreditation requirements. The 3rd parties medical screening labs in Beijing, Hangzhou and Guangzhou have actually been licensed by worldwide quality requirements and the regional healthcare commission and provided licenses to practice, with a yearly screening capability of 2 million individuals.

Subject: Press release summary

Source: EC Healthcare

Sectors: BioTech, Healthcare & & Pharm

http://www.acnnewswire.com

From the Asia Corporate News Network

Copyright © 2023 ACN Newswire. All rights booked. A department of Asia Corporate News Network.